Last
month, the Myelin Repair Foundation gathered the entire MRF research team
together for our annual research meeting, to strategize our pathway moving
forward into myelin repair clinical trials.
month, the Myelin Repair Foundation gathered the entire MRF research team
together for our annual research meeting, to strategize our pathway moving
forward into myelin repair clinical trials.
Our
team of approximately 60 scientists consists of clinical neurologists, cell
biologists, immunologists, genetics specialists, government experts and MRF
scientific staff members gathered by the bay to collaborate and discuss the
latest advances in myelin research towards developing a myelin repair therapeutic.
The MRF Principal Investigators presented their latest scientific results
alongside with their post-doctoral/graduate students, on posters and in Power
Point presentations. Dr. Henry McFarland, head of
the MRF Clinical Advisory Board, talked about the history of MS, which began in
the early 1300s, with the first known case of MS-an ice skating nun named Saint
Liduina of Schiedam. At another session, MRF CAB member Dr. Al Sandrock, Chief
Medical Officer and Senior Vice President of Development Sciences at Biogen
Idec presented the industry perspective of MS drug development, along with its
unique challenges and opportunities to meet patient need.
team of approximately 60 scientists consists of clinical neurologists, cell
biologists, immunologists, genetics specialists, government experts and MRF
scientific staff members gathered by the bay to collaborate and discuss the
latest advances in myelin research towards developing a myelin repair therapeutic.
The MRF Principal Investigators presented their latest scientific results
alongside with their post-doctoral/graduate students, on posters and in Power
Point presentations. Dr. Henry McFarland, head of
the MRF Clinical Advisory Board, talked about the history of MS, which began in
the early 1300s, with the first known case of MS-an ice skating nun named Saint
Liduina of Schiedam. At another session, MRF CAB member Dr. Al Sandrock, Chief
Medical Officer and Senior Vice President of Development Sciences at Biogen
Idec presented the industry perspective of MS drug development, along with its
unique challenges and opportunities to meet patient need.
By
gathering our world-class myelin experts together, from places as far as Europe
and Australia, the Myelin Repair Foundation facilitated important discussions
to strategize our path forward to bring a myelin repair therapeutic to multiple
sclerosis patients in 2019.
gathering our world-class myelin experts together, from places as far as Europe
and Australia, the Myelin Repair Foundation facilitated important discussions
to strategize our path forward to bring a myelin repair therapeutic to multiple
sclerosis patients in 2019.
Best,
Scott
Johnson
Johnson
President,
CEO and Founder
CEO and Founder
Myelin Repair Foundation
..
If you would like, you can comment to our blog posts
LIKE this Blog by clicking the LIKE button – top left
REMAIN up to date with MS News and Education
Visit: www.msviewsandnews.org to register
.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews